- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Elanco Animal Health (ELAN)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 505.00 mm | 505.00 mm | 505.00 mm | 505.00 mm | 505.00 mm | 505.00 mm |
| Cash burn (monthly) | 11.33 mm | (no burn) | 16.67 mm | 1.33 mm | (no burn) | (no burn) |
| Cash used (since last report) | 40.76 mm | n/a | 59.94 mm | 4.80 mm | n/a | n/a |
| Cash remaining | 464.24 mm | n/a | 445.06 mm | 500.20 mm | n/a | n/a |
| Runway (months of cash) | 41.0 | n/a | 26.7 | 375.2 | n/a | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 384 |
| Opened positions | 62 |
| Closed positions | 62 |
| Increased positions | 137 |
| Reduced positions | 136 |
| 13F shares | Current |
|---|---|
| Total value | 5.66 tn |
| Total shares | 507.44 mm |
| Total puts | 1.12 mm |
| Total calls | 1.16 mm |
| Total put/call ratio | 1.0 |
| Largest owners | Shares | Value |
|---|---|---|
| Dodge & Cox | 83.18 mm | $1.01 tn |
| Primecap Management | 51.17 mm | $619.61 bn |
| Vanguard | 48.76 mm | $590.50 bn |
| FMR | 40.23 mm | $487.21 bn |
| BLK BlackRock | 24.87 mm | $301.15 bn |
| Black Creek Investment Management | 20.43 mm | $247.46 bn |
| BAYRY Bayer | 18.45 mm | $538.64 mm |
| Dimensional Fund Advisors | 17.90 mm | $216.77 bn |
| T. Rowe Price Investment Management | 15.69 mm | $190.02 mm |
| Shapiro Capital Management | 12.36 mm | $149.64 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Jan 26 | Jeffrey N Simmons | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 23.47 | 117.991 | 2.77 k | 18,845.522 |
| 9 Jan 26 | Robert M VanHimbergen | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 23.47 | 8.112 | 190.39 | 8.112 |
| 9 Jan 26 | Rajeev A. Modi | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 23.47 | 60.274 | 1.41 k | 7,480.349 |
| 31 Dec 25 | Kapila K Anand | Common Stock | Grant | Acquire A | No | No | 22.63 | 381.131 | 8.62 k | 8,894.741 |
| 26 Dec 25 | Jeffrey N Simmons | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 22.6 | 122.533 | 2.77 k | 18,727.531 |